• Our Members
  • Events
  • Contact us
AMR Industry Alliance
  • About us
    • Why the AMR Industry Alliance?
    • How we work
  • Shared Goals
    • AMR Industry Declaration
    • Industry Roadmap for Progress on Combating Antimicrobial Resistance
    • Responsible Manufacturing
  • Why AMR?
  • Newsroom
  • Progress Report
  • In Action
Select Page
Aequor – ABD (Aequor Biofilm Dispersant) Effectively Combats AMR without Toxicity or Triggering Resistance

Aequor – ABD (Aequor Biofilm Dispersant) Effectively Combats AMR without Toxicity or Triggering Resistance

by mcwebmaster | Dec 15, 2017

Merck & Co., Inc. – Study for Monitoring Antimicrobial Resistance Trends (SMART)

Merck & Co., Inc. – Study for Monitoring Antimicrobial Resistance Trends (SMART)

by mcwebmaster | Dec 15, 2017

GSK – Appropriate Use Initiatives

GSK – Appropriate Use Initiatives

by mcwebmaster | Dec 15, 2017

bioMérieux – Collaborative project with Antwerp University (Pr Herman Goossens)

bioMérieux – Collaborative project with Antwerp University (Pr Herman Goossens)

by mcwebmaster | Dec 14, 2017

Da Volterra – DAV132

Da Volterra – DAV132

by mcwebmaster | Nov 17, 2017

Next Entries »

stay informed

Subscribe to receive our updates

about us

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

read more
contact

AMR Industry Alliance Secretariat (IFPMA)
Chemin des Mines 9
P.O. Box 195
1211 Geneva 20
Switzerland
Email: info@amrindustryalliance.org

© AMR Industry Alliance 2017 - Contact us - Cookies Policy - Privacy Policy - Terms of use - Privacy Centre - Careers